Representative Jared Moskowitz (D-Florida) recently sold shares of West Pharmaceutical Services, Inc. NYSE: WST. In a filing disclosed on December 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in West Pharmaceutical Services stock on November 8th. The trade occurred in the Representative's "MORGAN STANLEY ACTIVE ASSETS (1)" account.
Representative Jared Moskowitz also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Atmos Energy NYSE: ATO on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of Elevance Health NYSE: ELV on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of QUALCOMM NASDAQ: QCOM on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of Tractor Supply NASDAQ: TSCO on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 11/8/2024.
- Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 11/8/2024.
- Sold $50,001 - $100,000 in shares of Seacoast Banking Co. of Florida NASDAQ: SBCF on 11/8/2024.
West Pharmaceutical Services Trading Down 0.9 %
NYSE:WST traded down $2.89 on Tuesday, reaching $319.27. The stock had a trading volume of 302,112 shares, compared to its average volume of 564,292. The company has a market cap of $23.12 billion, a price-to-earnings ratio of 47.37, a P/E/G ratio of 24.47 and a beta of 1.01. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23. The firm's fifty day moving average is $311.01 and its two-hundred day moving average is $311.66.
West Pharmaceutical Services (NYSE:WST - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.35. The business had revenue of $746.90 million for the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The company's revenue was down .1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.16 EPS. Equities analysts expect that West Pharmaceutical Services, Inc. will post 6.64 EPS for the current fiscal year.
West Pharmaceutical Services Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th were issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 0.26%. This is a positive change from West Pharmaceutical Services's previous quarterly dividend of $0.20. The ex-dividend date was Wednesday, November 13th. West Pharmaceutical Services's dividend payout ratio is 12.46%.
Insider Activity at West Pharmaceutical Services
In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the completion of the sale, the vice president now owns 1,253 shares of the company's stock, valued at $388,931.20. This trade represents a 35.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of WST. Czech National Bank lifted its holdings in shares of West Pharmaceutical Services by 6.6% during the 2nd quarter. Czech National Bank now owns 13,881 shares of the medical instruments supplier's stock worth $4,572,000 after acquiring an additional 863 shares during the period. RFG Advisory LLC raised its holdings in West Pharmaceutical Services by 2.3% in the second quarter. RFG Advisory LLC now owns 1,499 shares of the medical instruments supplier's stock valued at $494,000 after buying an additional 34 shares during the period. Sequoia Financial Advisors LLC raised its holdings in West Pharmaceutical Services by 7.5% in the second quarter. Sequoia Financial Advisors LLC now owns 1,195 shares of the medical instruments supplier's stock valued at $394,000 after buying an additional 83 shares during the period. Diversified Trust Co raised its holdings in West Pharmaceutical Services by 96.6% in the second quarter. Diversified Trust Co now owns 1,626 shares of the medical instruments supplier's stock valued at $536,000 after buying an additional 799 shares during the period. Finally, V Square Quantitative Management LLC raised its holdings in West Pharmaceutical Services by 20.8% in the second quarter. V Square Quantitative Management LLC now owns 1,940 shares of the medical instruments supplier's stock valued at $639,000 after buying an additional 334 shares during the period. 93.90% of the stock is currently owned by hedge funds and other institutional investors.
About Representative Moskowitz
Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida's 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2025. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 23rd Congressional District. He declared candidacy for the Democratic primary scheduled on August 20, 2024. Moskowitz resigned his state House seat on January 11, 2019, to head the state's Division of Emergency Management. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor's degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz's career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.
About West Pharmaceutical Services
(
Get Free Report)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Recommended Stories
Before you consider West Pharmaceutical Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.
While West Pharmaceutical Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
